docs.healthdata.beProject name
Predictive Tests for a Therapeutic Response
Project abbreviation
PITTER
Project code
HDBP0078
Primary organization that oversees implementation of project
- National Institute for Health and Disability Insurance (RIZIV-INAMI)
Partner organization participating in project
- Sciensano
- Belgian Cancer Registry
Organization that commissioned this project
- National Institute for Health and Disability Insurance (RIZIV-INAMI)
Organization providing monetary or material support
- National Institute for Health and Disability Insurance (RIZIV-INAMI)
Brief project description
For a number of diseases/disorders, personalized treatment today offers a great added value compared to classical, empirical therapy. Thanks to molecular diagnostics, specific aberrations can be detected, which are an indication for a correct diagnosis and prognosis and the successful use of a corresponding drug in order to target the disease.
Currently the reimbursement of personalized medicines is not coupled with that of the accompanying biomarker which often leads to a delay in reimbursement of the predictive tests as compared to the personalized medicine. To better align reimbursement of the medicine and the predictive test, a reimbursement procedure will be created that will allow a monthly update of reimbursed personalized medicines and their corresponding predictive test, and as such will be flexible enough to adjust for the rapid evolving field of personalized medicine.